Market Size of Global Foot Drop Treatment Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 9.50 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Foot Drop Treatment Market Analysis
The Foot Drop Treatment Market is expected to register a CAGR of 9.5% during the forecast period, 2022-2027.
COVID-19 has uplifted the market studied in a way that ensures a long-term reliance of consumers on bone and joint health supplements. As hospitals are overwhelmed by COVID-19 patients, elective surgeries were canceled or indefinitely delayed. This, in turn, has led consumers toward immediate alternatives such as medications or supplements to ensure proper health, increasing the demand for associated industries, including bone and joint health ingredients. According to the National Osteoporosis Foundation (NOF) survey, osteoporosis patients continued appointments with doctors through various modes in COVID-19: 33% used telephone consultations, 21% used video consultations, 26% used face-to-face appointments, 18% used urgent 'in-person visits, and 3% used other modalities such as instant messaging or attendance for parenteral therapies. As a result, during major lockdowns, the market for foot drop treatment remained mostly unaffected.
A musculoskeletal disorder leads to restricted mobility and it is one of the major contributors worldwide to disability. Musculoskeletal disorder is one of the major causes of foot drop. According to the World Health Organization (WHO), facts published in July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Also, musculoskeletal conditions are the leading contributor to disability worldwide. As per the same source, high-income countries are the most affected in terms of several people - 441 million - followed by countries in the WHO Western Pacific Region with 427 million and the South-East Asia Region with 369 million. Musculoskeletal conditions are also the biggest contributor to years lived with disability (YLDs) worldwide with approximately 149 million YLDs, accounting for 17% of all YLDs worldwide. Thus the increase in musculoskeletal disorders worldwide requires the treatment of these disorders. Thus, the market is expected to see a surge over the forecast period.
Moreover, Heliyon published a study in 2020 in which a pedi-anklebot robot was evaluated for foot drop treatment. Ankle motor performance was measured, and great accuracy in ankle trajectories was observed. Hence, the new emerging treatment options are expected to drive the global foot drop treatment market in the forecast period.
However, the high cost of functional electrical stimulators is likely to impede the market growth over the forecast period.
